| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.78B | 28.03B | 25.44B | 22.44B | 24.06B | 23.72B |
| Gross Profit | 6.17B | 6.92B | 6.15B | 5.26B | 5.88B | 7.19B |
| EBITDA | 3.93B | 4.51B | 3.94B | 3.29B | 3.95B | 5.26B |
| Net Income | 2.37B | 2.28B | 2.36B | 1.74B | 2.23B | 3.24B |
Balance Sheet | ||||||
| Total Assets | 54.55B | 61.69B | 54.30B | 52.93B | 50.06B | 49.49B |
| Cash, Cash Equivalents and Short-Term Investments | 20.20B | 20.78B | 15.42B | 19.69B | 18.81B | 16.99B |
| Total Debt | 140.00M | 0.00 | 264.28M | 374.53M | 374.74M | 374.88M |
| Total Liabilities | 8.12B | 10.87B | 7.83B | 7.27B | 6.70B | 7.51B |
| Stockholders Equity | 46.43B | 50.82B | 46.48B | 45.66B | 43.36B | 41.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.84B | 1.70B | 1.99B | 2.42B | 1.46B |
| Operating Cash Flow | 0.00 | 3.39B | 3.30B | 3.10B | 3.06B | 2.76B |
| Investing Cash Flow | 0.00 | 4.12B | -11.45B | -1.32B | -655.42M | -954.77M |
| Financing Cash Flow | 0.00 | -2.03B | -1.27B | -999.52M | -633.05M | -981.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥176.43B | 12.35 | ― | 3.50% | 4.44% | 4.49% | |
76 Outperform | ¥87.39B | 18.62 | 6.31% | 4.01% | 1.41% | 7.59% | |
76 Outperform | ¥52.52B | 8.97 | ― | 5.04% | -6.31% | 6.66% | |
72 Outperform | ¥34.80B | 12.94 | ― | 2.37% | -1.11% | -3.98% | |
68 Neutral | ¥39.06B | 20.31 | ― | 3.77% | 10.19% | -3.24% | |
65 Neutral | ¥53.35B | 19.62 | ― | 4.37% | -3.84% | -43.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |